tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Casey Woodring, 9 are a HOLD (47.37%), 3 are a SELL (15.79%), 7 are a BUY (36.84%).
Analyst Casey Woodring, currently employed at JPMORGAN, carries an average stock price target met ratio of 36.11% that have a potential upside of 6.11% achieved within 21 days.
Casey Woodring’s has documented 38 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRL, Charles River Laboratories at 03-Feb-2025.
Analyst best performing recommendations are on SHC (SOTERA HEALTH CO).
The best stock recommendation documented was for QDEL (QUIDEL) at 11/3/2022. The price target of $93 was fulfilled within 8 days with a profit of $5.48 (6.26%) receiving and performance score of 7.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$45
$16.87 (59.97%)
$50
1 months 25 days ago
(13-Feb-2025)
1/3 (33.33%)
$3.35 (8.04%)
42
Hold
$43
$14.87 (52.86%)
$80
3 months 28 days ago
(10-Dec-2024)
7/7 (100%)
$4.5 (11.69%)
196
Buy
$57
$28.87 (102.63%)
$50
7 months 2 days ago
(05-Sep-2024)
5/13 (38.46%)
$12.5 (28.09%)
154
Buy
$76
$47.87 (170.17%)
$100
1 years 1 months 24 days ago
(14-Feb-2024)
2/9 (22.22%)
$30.73 (67.88%)
16
Sell
$37
$8.87 (31.53%)
$85
1 years 1 months 24 days ago
(14-Feb-2024)
2/4 (50%)
$-8.27 (-18.27%)
65
Which stock is Casey Woodring is most bullish on?
Which stock is Casey Woodring is most reserved on?
What Year was the first public recommendation made by Casey Woodring?
